Developing vaccines against pandemic influenza

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 356, Issue 1416, 2001, Pages 1953-1960

  Wood, John M ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Avian influenza; Influenza; Pandemic plan; Vaccine

Indexed keywords

INFLUENZA;

AVES; SUS SCROFA;

INFLUENZA VACCINE;

ANTIBODY PRODUCTION; ARTICLE; DRUG DESIGN; EPIDEMIC; HISTORY; HUMAN; IMMUNOLOGY; INFLUENZA;

ANTIBODY FORMATION; DISEASE OUTBREAKS; DRUG DESIGN; HISTORY, 20TH CENTURY; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN;

EID: 0035969787     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.2001.0981     Document Type: Conference Paper

References (35)

1. Evaluation and control of vaccines for the National Influenza Immunization Program
2. Influenza immunization. Clinical studies with ether-split subunit vaccines
3. Inactivated influenza vaccines prepared in cell culture
4. Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from human in Hong Kong
5. A field evaluation of inactivated, zonal-centrifuged influenza vaccines in children in Chapel Hill, North Carolina, 1968-69
6. Planning for the next pandemic
7. Responses of volunteers to inactivated influenza virus vaccines
8. Future influenza vaccines and the use of genetic recombinants
9. Summary of clinical trials of inactivated influenza vaccine - 1978
10. An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines
11. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses
12. Antibody responses and reactogenicity of graded doses of inactivated influenza A/New Jersey/76 whole virus vaccine in humans
13. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
14. Effect of vaccination of a school-age population upon the course of an A2/Hong Kong influenza epidemic
15. Studies with inactivated influenza vaccines purified by zonal centrifugation 1. Adverse reactions and serological responses
16. Some problems in the standardization and control of influenza vaccine in 1957
17. Production and testing in the USA of influenza virus vaccine made from the Hong Kong variant in 1968-69
18. Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: Serological responses and clinical reactions
19. Confronting a potential H5N1 pandemic: A randomised controlled trial of conventional and MF59 adjuvanted influenza A/duck/Singapore/97 (H5N3) surface antigen vaccine
20. Summary of clinical trials of influenza virus vaccines in adults
21. Chronicle of influenza pandemics
22. Reactogenicity and immunogenicity of inactivated influenza A (H1N1) virus vaccine in unprimed children. Report to the Medical Research Council committee on influenza and other respiratory virus vaccines
23. ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus
24. Haemagglutination-inhibiting antibody response to and efficacy of inactivated Hong Kong influenza vaccine
25. Avirulent avian influenza virus as a vaccine strain against a potential human pandemic
26. Effect of dosage and route of inoculation upon antigenicity of inactivated influenza virus vaccine (Hong Kong strain) in man
27. Safety and immunogenicity of a recombinant haemagglutinin vaccine for H5 influenza in humans
28. An evaluation of influenza immunization. Influence of route of administration and vaccine strain
29. WHO influenza surveillance
30. History of inactivated influenza vaccines
31. Vaccines against H5N1 influenza
32. Trials of influenza A/New Jersey/76 virus vaccine in normal children: An overview of age-related antigenicity and reactogenicity